{"result": "(\"entity\"<|>HEPATITIS<|>EVENT<|>Hepatitis is a medical condition characterized by inflammation of the liver, often caused by viral infections, alcohol consumption, or autoimmune diseases.)\n##\n(\"entity\"<|>CIRRHOSIS<|>EVENT<|>Cirrhosis is a late-stage liver disease characterized by scarring (fibrosis) of the liver, often resulting from chronic liver diseases such as hepatitis and alcohol abuse.)\n##\n(\"entity\"<|>LIVER TRANSPLANTATION<|>EVENT<|>Liver transplantation is a surgical procedure to replace a diseased liver with a healthy liver from a donor, often performed on patients with end-stage liver disease.)\n##\n(\"entity\"<|>NUTRITIONAL STATUS<|>EVENT<|>Nutritional status refers to the condition of the body in relation to the intake and utilization of nutrients, which can significantly affect health outcomes, especially in patients with liver disease.)\n##\n(\"entity\"<|>MØLLER S<|>PERSON<|>Møller S is a researcher who has contributed to studies on prognostic variables in patients with liver diseases, particularly cirrhosis and its complications.)\n##\n(\"entity\"<|>BENDTSEN F<|>PERSON<|>Bendtsen F is a researcher involved in studies related to liver diseases, focusing on prognostic factors in patients with cirrhosis.)\n##\n(\"entity\"<|>CHRISTENSEN E<|>PERSON<|>Christensen E is a researcher who has worked on studies concerning liver cirrhosis and its complications.)\n##\n(\"entity\"<|>HEURIKSEN J H<|>PERSON<|>Heuriksen J H is a researcher who has contributed to the understanding of liver diseases, particularly cirrhosis and its prognostic variables.)\n##\n(\"entity\"<|>TAJIKA M<|>PERSON<|>Tajika M is a researcher who has studied the impact of energy metabolism on the survival of patients with liver cirrhosis.)\n##\n(\"entity\"<|>KATO M<|>PERSON<|>Kato M is a researcher involved in studies on liver cirrhosis and its nutritional management.)\n##\n(\"entity\"<|>MIWA Y<|>PERSON<|>Miwa Y is a researcher who has contributed to studies on liver diseases, particularly focusing on energy metabolism in cirrhosis patients.)\n##\n(\"entity\"<|>MOHRI H<|>PERSON<|>Mohri H is a researcher who has studied the effects of nutritional status on liver disease outcomes.)\n##\n(\"entity\"<|>MORIWAKI H<|>PERSON<|>Moriwaki H is a researcher involved in studies related to liver cirrhosis and its complications.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPLEMENTATION<|>EVENT<|>Nutritional supplementation refers to the provision of nutrients to patients, particularly those with liver disease, to improve their health outcomes.)\n##\n(\"relationship\"<|>MØLLER S<|>CIRRHOSIS<|>Møller S has conducted research on prognostic variables in patients with cirrhosis, indicating a direct involvement in the study of this condition<|>8)\n##\n(\"relationship\"<|>BENDTSEN F<|>CIRRHOSIS<|>Bendtsen F has contributed to research on cirrhosis, focusing on its prognostic factors<|>8)\n##\n(\"relationship\"<|>CHRISTENSEN E<|>CIRRHOSIS<|>Christensen E has been involved in studies related to cirrhosis, indicating a connection to this liver condition<|>8)\n##\n(\"relationship\"<|>HEURIKSEN J H<|>CIRRHOSIS<|>Heuriksen J H has researched cirrhosis and its complications, showing a relationship with this condition<|>8)\n##\n(\"relationship\"<|>TAJIKA M<|>CIRRHOSIS<|>Tajika M's research on energy metabolism in cirrhosis patients indicates a direct relationship with the condition<|>7)\n##\n(\"relationship\"<|>KATO M<|>CIRRHOSIS<|>Kato M has studied the nutritional management of cirrhosis, linking him to this liver disease<|>7)\n##\n(\"relationship\"<|>MIWA Y<|>CIRRHOSIS<|>Miwa Y's research on energy metabolism in cirrhosis patients shows a connection to the disease<|>7)\n##\n(\"relationship\"<|>MOHRI H<|>CIRRHOSIS<|>Mohri H has studied the effects of nutritional status on cirrhosis outcomes, indicating a relationship with the condition<|>7)\n##\n(\"relationship\"<|>MORIWAKI H<|>CIRRHOSIS<|>Moriwaki H's involvement in cirrhosis research indicates a relationship with this liver disease<|>7)\n##\n(\"relationship\"<|>NUTRITIONAL SUPPLEMENTATION<|>LIVER TRANSPLANTATION<|>Nutritional supplementation is often critical for patients undergoing liver transplantation to improve outcomes<|>6)\n##\n(\"relationship\"<|>NUTRITIONAL STATUS<|>CIRRHOSIS<|>Nutritional status is a significant factor affecting the prognosis of patients with cirrhosis<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: osis. Hepatology 1996; 23:1041-1046.\n\n101. Møller S, Bendtsen F, Christensen E, Heuriksen J H. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol 1994; 21:940-946.\n\n102. Tajika M, Kato M, Miwa Y, Mohri H, Moriwaki H. Energy metabolism determines the survival of patients with liver cirrhosis, In: Yamanaka M, Toda G, Tanaka T, editors. Progress in Hepatology, vol. 4, Liver Cirrhosis Update. Amsterdam, The Netherlands: Elsevier, 1998, pp. 115-23.\n\n103. Kalaitzakis E, Olsson R, Henfridsson P, et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007; 27(9):1194-201.\n\n104. Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacte-\n---\nTema 16. Soporte nutricional en la hepatopatía crónica y trasplante hepático 285\n\nrial infections. Clin Gastroenterol Hepatol. 2010; 8(11):979-85\n\n105. Shahid M, Johnson J, Nightingale P, et al. Nutritional markers in liver allograft recipients. Transplantation. 2005; 79(3):359-62.\n\n106. Hanai T, Shiraki M, Nishimura K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015 Jan;31(1):193-9.\n\n107. Nardelli S, Lattanzi B, Torrisi S, et al. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clin Gastroenterol Hepatol. 2016 Nov 2. pii: S1542-3565(16)30999-5. doi: 10.1016/j.cgh.2016.10.028. [Epub ahead of print]\n\n108. Ruegg MA, Glass DJ. Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol. 2011; 51:373-95.\n\n109. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010; 211(2):271-8.\n\n110. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Sarcopenia is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012 Feb;10(2):166-73.\n\n111. Moukarzel AA, Najm I, Vargas J, et al. Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc 1990; 22:1560.\n\n112. Merli M, Giusto M, Gentili F, et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010; 30(2):208-14.\n\n113. Iritani S, Imai K, Takai K, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol. 2015; 50(3):323-32.\n\n114. Ney M, Vandermeer B, van Zanten SJ, Ma MM, Gramlich L, Tandon P. Metaanalysis: oral or enteral nutritional supplementation in cirrhosis. Aliment Pharmacol Ther 2013; 37:672-679.\n\n115. Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev 2012; 5:CD008344.\n\n116. Plauth M, Cabré E, Campillo B, Kondrup J, Marchesini G, Schütz T, Shenkin A, Wendon J; ESPEN.. ESPEN Guidelines on Parenteral Nutrition: hepatology. Clin Nutr. 2009 Aug; 28(4):436-44.\n\n117. Nielsen K, Kondrup J, Martinsen L, Stilling B, Vikman B. Nutritional assessment and adequacy of dietary intake in hospitalised patients with alcoholic liver disease. Br J Nutr 1993; 69: 665-79.\n\n118. Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology. 2013; 58(1):325-36.\n\n119. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams Nompleggi DJ, Bonkovsky HL. Nutritional supplementation in chronic liver disease: an analytical review. Hepatology 1994; 19:518-3.\n\n120. Miwa Y, Shiraki M, Kato M, Tajika M, Mohri H, Murakami N, et al. Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}